“…The supplementation with either antioxidant, a pan-caspase-inhibitor or a ferroptosis inhibitor, all partially rescued lymphoma cells from terminal cell death, which contributes to the mechanistic understanding of this combination treatment.Cancers 2020, 12, 845 2 of 20 mitochondrial/intrinsic to receptor/extrinsic pathways as well as caspase-or Bcl-2 (B-cell lymphoma 2)-independent mechanisms [21][22][23].Pulsed electric fields in the microsecond range (µsPEFs) are used in electrochemotherapy [24]. Application of µsPEF is an accredited anticancer therapy in the clinics [25]. µsPEFs transiently compromise the plasma cell membrane integrity of the cancer cells, allowing the chemotherapeutics, e.g., bleomycin and cisplatin, to enter the cell [26,27].…”